FindTrial
Sign In

Safety and efficacy of skin care formulation

PRIMARY OBJECTIVE To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of even skin tone, reduction in pigmentation (dark spot) & radiant skin on healthy male & female subjects. SECONDARY OBJECTIVE To evaluate the in-vivo efficacy of a skin care formulation in terms signs of ageing: minimize fine lines, smooth skin texture, reducing dark circles and improvement in hydration on healthy male & female subjects - N/AP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039184
Enrollment
36
Registered
2022-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: FACE OIL:Product A: Application will be carried out on face, once in day for the period of 28 days. Control Intervention1: NIL: NIL

Sponsors

Kama Ayurveda Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Having dull skin and uneven skin tone Having pigmentary spot on the face of grade 2 to grade 6 according to the Bazins atlas Having Crows feet wrinkle of grade 2 and above according to the Bazins atlas Having visible under eye dark circle

Exclusion criteria

Exclusion criteria: Having started, changed or interrupted one hormonal treatment during the past 3 months Having started, changed or stopped her tobacco consumption in the previous 6 months Having consumed caffeine-based products, alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements Having taken a medicinal treatment which could lead to hyper pigmentation in the previous 6 months Taking oral supplements with major or minor effect on whitening of skin Having had beauty treatment e.g. skin cleansing, exfoliation, scrub, mask or having applied self tanning products in the week preceding the start of the study Having applied products with anti-wrinkle action in the 2 weeks preceding the start of the study Having applied products with a depigmenting/ whitening action in the 4 weeks preceding the start of the study Having undergone physical and/or chemical treatments of the spots in the previous 6 months Having a suntanned skin on the studied areas which could interfere with the evaluations of the study For males, having not shaved their beard 24 hours prior to the day of measurement

Design outcomes

Primary

MeasureTime frame
evaluate of efficacy and safety of a skin care formulation in terms of even skin tone, reduction in pigmentation (dark spot), radiant skinTimepoint: T0, T14 days and T28 days—

Secondary

MeasureTime frame
efficacy of a skin care formulation in terms signs of ageing: minimize fine lines, smooth skin texture, reducing dark circles and improvement in hydrationTimepoint: T0, T14 days and T28 days—

Countries

India

Contacts

Public ContactMr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026